Embed Code Copied

Mar 10, 2016 1:57 PM

Could abuse resistant pain-killers help in fight against NH opioid crisis?


CONCORD - With the Granite State facing an opioid epidemic, here's something to consider. Many addicts became addicted after being prescribed a drug for a legitimate health problem. What if those prescriptions drugs weren't addictive to start?

A new national survey reports 65% of U.S. adults believe the Food & Drug Administration should require pharmaceutical companies to include an abuse deterrent formulation (ADF) in all of their most abused drugs, both name-brand and generic.

ADF’s help prevent the crushing, snorting and injecting of prescription painkillers - the things that give an abuser an immediate high.
The FDA has approved labels for 5 Schedule II drugs with abuse deterrent properties.

Nine states have passed legislation related to ADF prescribing in one form or stage or another, but there's no national mandate in place. The list includes Maine, Massachusetts, Maryland, Colorado, Nevada, Tennessee, Utah, Indiana and Missouri.

In a study conducted by Repass Research of over 1500 U.S. respondents in February 2016, two-thirds of those surveyed said they support mandating ADF's within 4 years, and 65% said the government putting efforts toward prevention is equal to addiction treatment.

According to another study out of George Mason University, government upfront ADF costs are less than addiction treatment costs.

--  Need a new car or even a boat? Click here to check out the all-new NH1 Motors --



Must Read on NH1.com

NH1 Dining

NH1 on Facebook

NH1 on Twitter